Spectral AI (MDAI) Competitors

Pulmonx (NASDAQ:LUNG) and Spectral AI (NASDAQ:MDAI) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, media sentiment, valuation, risk, earnings, profitability, institutional ownership, analyst recommendations and community ranking.

Does the MarketBeat Community favor LUNG or MDAI?

Pulmonx received 32 more outperform votes than Spectral AI when rated by MarketBeat users. However, 100.00% of users gave Spectral AI an outperform vote while only 47.56% of users gave Pulmonx an outperform vote.

Company	Underperform	Outperform
Pulmonx	Outperform Votes 39 47.56%	Underperform Votes 43 52.44%
Spectral AI	Outperform Votes 7 100.00%	Underperform Votes No Votes

Do analysts prefer LUNG or MDAI?

Pulmonx presently has a consensus price target of $12.07, suggesting a potential upside of 284.44%. Spectral AI has a consensus price target of $4.75, suggesting a potential upside of 244.20%. Given Pulmonx's higher probable upside, equities research analysts plainly believe Pulmonx is more favorable than Spectral AI.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Pulmonx	0 Sell rating(s)	2 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.78
Spectral AI	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	3.33

Is LUNG or MDAI more profitable?

Spectral AI has a net margin of -40.78% compared to Pulmonx's net margin of -67.31%. Spectral AI's return on equity of 0.00% beat Pulmonx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Pulmonx	-67.31%	-55.36%	-33.53%
Spectral AI	-40.78%	N/A	-77.87%

Does the media prefer LUNG or MDAI?

In the previous week, Spectral AI had 2 more articles in the media than Pulmonx. MarketBeat recorded 6 mentions for Spectral AI and 4 mentions for Pulmonx. Pulmonx's average media sentiment score of 1.15 beat Spectral AI's score of 0.73 indicating that Pulmonx is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Pulmonx	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Spectral AI	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has better valuation & earnings, LUNG or MDAI?

Spectral AI has lower revenue, but higher earnings than Pulmonx. Spectral AI is trading at a lower price-to-earnings ratio than Pulmonx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Pulmonx	$87.47M	1.45	-$60.84M	-$1.44	-2.18
Spectral AI	$29.58M	1.18	-$20.85M	-$0.54	-2.56

Which has more risk & volatility, LUNG or MDAI?

Pulmonx has a beta of 0.65, suggesting that its stock price is 35% less volatile than the S&P 500. Comparatively, Spectral AI has a beta of 0.59, suggesting that its stock price is 41% less volatile than the S&P 500.

Do institutionals & insiders hold more shares of LUNG or MDAI?

91.0% of Pulmonx shares are held by institutional investors. Comparatively, 67.1% of Spectral AI shares are held by institutional investors. 6.8% of Pulmonx shares are held by insiders. Comparatively, 56.7% of Spectral AI shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

Spectral AI beats Pulmonx on 10 of the 19 factors compared between the two stocks.